Copertina

Clinical Responses and Transcriptomic Analysis of Spesolimab in a Girl With Severe Dermatitis, Multiple Allergies and Metabolic Wasting Syndrome

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Jinxiang Yang, Guofang Li, Yidong Tan, Bing Wang, Mingjun Lyu, Yijun Yang, Zhen Zhang, Yan Gu, ZhiRong Yao, Jianying Liang
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Experimental Dermatology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Subcutaneous Spesolimab for Amicrobial Pustulosis of the Folds
di: Angelo Valerio Marzano, et al.
Pubblicazione: (2026)

Spesolimab for Generalized Pustular Psoriasis in the Late Second Trimester of Pregnancy
di: Miyuki Kato, et al.
Pubblicazione: (2026)

Spesolimab in refractory paediatric acrodermatitis continua of Hallopeau, a case series
di: Liting Cai, et al.
Pubblicazione: (2024)

Refractory Pediatric Generalized Pustular Psoriasis Successfully Treated With Spesolimab
di: Bo Peng, et al.
Pubblicazione: (2025)

Lymphomatoid Papulosis Following Spesolimab Treatment for Generalised Pustular Psoriasis
di: Mizuho Namba, et al.
Pubblicazione: (2025)

Comment on “Food Allergy Test‐Guided Dietary Advice for Children With Atopic Dermatitis: A Consensus Study”
di: Ankan Gupta
Pubblicazione: (2026)

Reply to Comment on ‘Food Allergy Test‐Guided Dietary Advice for Children With Atopic Dermatitis: A Consensus Study’
di: Matthew J. Ridd, et al.
Pubblicazione: (2026)

Atopic Dermatitis in Indonesian Children: Association of Toilet Seat Dermatitis With Moderate–Severe Manifestation and Low Prevalence of Loss‐of‐Function Filaggrin Gene Variants
di: Raden Mohamad Rendy Ariezal Effendi, et al.
Pubblicazione: (2025)

Combination Therapy With Upadacitinib and Dupilumab for Severe Atopic Dermatitis
di: Amaia Barrutia‐Etxebarria, et al.
Pubblicazione: (2025)

Severe Erosive Lichen Planus Causing Vaginal Stenosis in a Young Girl
di: Apoorva Sharma, et al.
Pubblicazione: (2025)

Dupilumab in Combination With JAK Inhibitor for Refractory Moderate‐to‐Severe Atopic Dermatitis
di: Xiaoting Song, et al.
Pubblicazione: (2024)

Identification of Polyamine Metabolism‐Related Biomarkers in Psoriasis: A Study Based on Transcriptomics and Single‐Cell Sequencing
di: Li Zhang, et al.
Pubblicazione: (2026)

Association Between Food Allergy Status and Atopic Dermatitis Control and Persistence: A Longitudinal Analysis of the Pediatric Eczema Elective Registry
di: Jessica J. Wong, et al.
Pubblicazione: (2024)

Lebrikizumab After Multiple Prior Advanced Therapies in Moderate‐To‐Severe Atopic Dermatitis: A Real‐World Case Series
di: Giovanni Paolino, et al.
Pubblicazione: (2026)

Correction to “Spesolimab: A Comprehensive Review on the Anti‐ IL ‐36 Receptor Antibody in Dermatology”
Pubblicazione: (2025)

Dupilumab‐Induced Psoriasis in an Adolescent With Severe Atopic Dermatitis: Successful Management With Abrocitinib
di: Grigorios Theodosiou, et al.
Pubblicazione: (2026)

A Pediatric Case of Severe Atopic Dermatitis on Dupilumab Treatment and Pulmonary Tuberculosis
di: Maria Efenesia Baffa, et al.
Pubblicazione: (2025)

Topical Mercury Allergic Contact Dermatitis Evolving Into Drug Related Eosinophilia With Systemic Symptoms ( DRESS )
di: Zhi Yi Alicia Seet, et al.
Pubblicazione: (2026)

Multiple Cutaneous Cysts in Nevoid Basal Cell Carcinoma Syndrome
di: Wei Wen, et al.
Pubblicazione: (2025)

A Case of Lipschütz Ulcers in a 13‐Year‐Old Girl With PFAPA Syndrome
di: Remi Parker, et al.
Pubblicazione: (2025)

Platelet‐Derived Extracellular Vesicles Alleviate Psoriatic Inflammation via Mitochondrial Transfer to Macrophages
di: Bing Wang, et al.
Pubblicazione: (2025)

A Novel Report of Müllerian (Vaginal/Uterine) Agenesis in a Newborn Girl With LUMBAR Syndrome
di: Sonia A. Havele, et al.
Pubblicazione: (2025)

An Observational Study of Early Treatment Response and Predictors of Dupilumab in the Treatment of Moderate‐to‐Severe Atopic Dermatitis
di: Sisi Deng, et al.
Pubblicazione: (2024)

The Use of Dupilumab for Severe Atopic Dermatitis in Patients Aged Under 12‐Years
di: Laura Wheller, et al.
Pubblicazione: (2026)

Radiotherapy‐Induced Stevens–Johnson Syndrome/ Toxic Epidermal Necrolysis in an Adolescent Girl With Diffuse Glioma of the Pons
di: Terri Chiong, et al.
Pubblicazione: (2024)

Serum YKL‐40 Levels as a Biomarker for Disease Severity and Therapeutic Response in Atopic Dermatitis Patients
di: Jiaming Fan, et al.
Pubblicazione: (2025)

Real‐Life Effectiveness of Abrocitinib and Predictors of Response in Adults With Moderate‐To‐Severe Atopic Dermatitis
di: Eugenia Veronica Di Brizzi, et al.
Pubblicazione: (2026)

Severe Striae Distensae in the Setting of Pediatric Nephrotic Syndrome
di: Koral Cohen, et al.
Pubblicazione: (2025)

Long‐Term Effectiveness of Dupilumab in Moderate‐to‐Severe Atopic Dermatitis Across Different Body Regions in Extended Dosing‐Interval Regimens: A Real‐World Chinese Study
di: Yunmin Zou, et al.
Pubblicazione: (2025)

Real‐World Safety Profile of Spesolimab in Generalized Pustular Psoriasis: Insights From Japan as Part of a Multinational Expanded Access Program ( EAP )
di: Akimichi Morita, et al.
Pubblicazione: (2025)

Amoxicillin‐Triggered Flare of Generalized Pustular Psoriasis in a Patient With Homozygous IL36RN Pathogenic Variant Treated With Spesolimab and Cyclosporin A
di: Koki Morita, et al.
Pubblicazione: (2025)

Prevalence and Severity of Mental Health Symptoms With Seborrheic Dermatitis: A Systematic Review and Meta‐Analysis
di: Jiaqi Chen, et al.
Pubblicazione: (2025)

Nemolizumab Treatment for Severe Atopic Dermatitis Led to the Simultaneous Improvement of Coexisting Refractory Alopecia Areata: A Case Report
di: Moemi Hashimoto, et al.
Pubblicazione: (2025)

Topical Application of Fluoxetine Improves DNCB‐Induced Atopic Dermatitis in Mice
di: Xue Jiang, et al.
Pubblicazione: (2025)

Noncoding RNAs in Atopic Dermatitis: Insight Into Inflammation and Immune Regulation
di: Lemei Zhu, et al.
Pubblicazione: (2025)

Efficacy and Safety of GR1802 in Patients With Moderate‐to‐Severe Atopic Dermatitis: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Phase 2 Trial
di: Shangshang Wang, et al.
Pubblicazione: (2025)

Multiple Blue Nodules and Severe Anemia in a Child
di: Ayush Jain, et al.
Pubblicazione: (2025)

The Usefulness of Atopic Dermatitis Control Tool in Upadacitinib Treatment for Patients with Atopic Dermatitis
di: Teppei Hagino, et al.
Pubblicazione: (2024)

Real‐World Effectiveness and Safety of Lebrikizumab in Moderate‐to‐Severe Atopic Dermatitis: A Multicenter Study From Spain
di: Jose Carlos Armario‐Hita, et al.
Pubblicazione: (2025)

Comparative Safety Analysis of JAK Inhibitors in the Treatment of Atopic Dermatitis: Based on the FAERS Database
di: Zijun Song, et al.
Pubblicazione: (2026)